Cure of Helicobacter pylori infection in all compliant patients:  report on 644 subjects.
Seppälä
Kari
K
Kosunen
Timo U
TU
Veijola
Lea
L
Sipponen
Pentti
P
Arkkila
Perttu E T
PE
Rautelin
Hilpi
H
Tilvis
Reijo
R
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage; D015331:Cohort Studies; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008826:Microbial Sensitivity Tests; D010349:Patient Compliance; D012189:Retrospective Studies; D018570:Risk Assessment; D017211:Treatment Failure; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D017291:Clarithromycin